Neuropsychological impairment in human immunodeficiency virus-positive children;Alteraciones neuropsicológicas en niños infectados por el virus de inmunodeficiencia humana

Revista de Neurologia

Volumn 44, Issue 6, 2007, Pages 366-374

  Millana Cuevas, L C ^a   Portellano Pérez, José Antonio ^a,b   Martinez Arias R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Campus de Somosaguas   (Spain)

Author keywords

AIDS; Cognitive impairment; HIV; Neuropsychological assessment; Neuropsychological tests; Progressive encephalopathy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PATIENT ASSESSMENT; REVIEW; ADOLESCENT; CHILD; CHILD DEVELOPMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LANGUAGE; METABOLISM; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD DEVELOPMENT; COGNITION DISORDERS; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; LANGUAGE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS;

EID: 34250354062     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4406.2005612     Document Type: Review

References (75)

1. ONUSIDA. Informe sobre la epidemia mundial de sida (2004). URL: http://www.unaids.org. [06.02.2005].
2. Epstein LG, Gelbard HA. HIV-1-induced neuronal injury in the developing brain. J Leukoc Biol 1999; 65: 453-7.
3. Dickson DW, Belman AL, Park YD, Wiley C, Horoupian DS, Llena J, et al. Central nervous system pathology in pediatric aids: an autopsy study. APMIS 1989; 8 (Suppl): 40-57.
4. DeCarli C, Civitello LA, Brouwers P, Pizzo PA. The prevalence of computed axial tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immunodeficiency virus. Ann Neurol 1993; 34: 198-205.
5. Mintz M. Neurological and developmental problems in pediatric HIV infection. J Nutr 1996; 126: 2663-76.
6. Belman AL. Pediatric neuro-aids. Neuroimaging Clin N Am 1997; 7: 593-613.
7. Brouwers P, DeCarli C, Civitello L, Moss H, Wolters P, Pizzo P. Correlation between computed tomographic brain scan abnormalities and neuropsychological function in children with symptomatic human immunodeficiency virus disease. Arch Neurol 1995; 52: 39-44.
8. Brouwers P, DeCarli C, Heyes MP, Moss HA, Wolters PL, Tudor-Williams G, et al. Neurobehavioral manifestations of symptomatic HIV-1 disease in children: can nutritional factors play a role? J Nutr 1996; 126: 2651-62.
9. Brouwers P, Heyes MP, Moss HA, Wolters PL, Poplack D, Markey S, et al. Quinolitic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type-1 disease: relationships to clinical status and therapeutic response. J Infect Dis 1993; 168: 1380-6.
10. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994; 94: 883-91.
11. Mellins CA, Levenson RL, Zawadzki R, Kairam R, Weston M. Effects of pediatric HIV infection and prenatal drug exposure on mental and psychomotor development. J Pediatr Psychol 1994; 19: 617-28.
12. Drotar D, Olness K, Wiznizer M, Guay L, Marum L, Svilar G, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics 1997; 100: 5-11.
13. Drotar D, Olness K, Wiznizer M, Schatschneider C, Marum L, Guay L, et al. Neurodevelopmental outcomes of Ugandan infants with HIV infection: an application of growth curve analysis. Health Psychol 1999; 18: 114-21.
14. Knight WG, Mellins CA, Levenson RL, Arpadi SM, Kairam R. Brief report: effects of pediatric HIV infection on mental and psychomotor development. J Pediatr Psychol 2000; 25: 583-7.
15. Blanchette N, Smith ML, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infection. Brain Cogn 2001; 46: 50-3.
16. Havens J, Whtaker A, Feldman J, Alvarado L, Ehrhardt AA controlled study of cognitive and language function in school-age HIV-infected children. Ann N Y Acad Sci 1993; 693: 249-51.
17. Levenson RL, Mellins CA, Zawadzki R, Kairam R, Stein Z. Cognitive assessment of human immunodeficiency virus-exposed children. Am J Dis Child 1992; 146: 1479-83.
18. Tardieu M, Mayaux MJ, Seible N, Funck I, Straub E, Teglas JP, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 1995; 126: 375-9.
19. Bisiacchi PS, Suppiej A, Laverda A. Neuropsychological evaluation of neurologically asymptomatic HIV-infection children. Brain Cogn 2000; 43: 49-52.
20. Cohen S, Mundy T, Karrasik B, Lieb L, Ludwig D, Ward J. Neuropsychological functioning in human immunodeficiency virus type 1 seropositive children infected through neonatal blood transfusion. Pediatrics 1991; 88: 58-68.
21. Whitt JK, Hooper SR, Tennison MB, Robertson WT, Gold SH, Burchinal M, et al. Neuropsychologic functioning of human immunodeficiency virus-infected children with hemophilia. J Pediatr 1993; 122: 52-9.
22. Englund JA, Baker CJ, Raskino C, McKinney RE, Lifschitz MH, Petrie B, et al. Clinical and laboratory characteristics of a large cohort of symptomatic human immunodeficiency virus-infected infants and children. Pediatr Infect Dis J 1996; 15: 1025-36.
23. Banks M. The role of neuropsychological testing and evaluation: when to refer. Adolesc Med 2002; 13: 643-64.
24. Loveland K, Stehbens JA, Mahoney EM, Sirois PA, Nichols S, Bordeaux JD, et al. Declining immune function in children and adolescents with hemophilia and HIV infection: effects on neuropsychological performance. J Pediatr Psychol 2000; 25: 309-22.
25. Brouwers P, Moss H, Wolters P, Schmitt FA. Developmental deficits and behavioral change in pediatric aids. In Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press; 1994. p. 310-38.
26. Portellano JA, Millana LC. Aspectos neuropsicológicos del sida infantil. Polibea 2000; 56: 14-9.
27. Wachtel RC, McGrath C, Houck D, Chmielewski D, Tepper VJ. Fine motor testing in children: not fine. Pediatric AIDS and HIV infection: Fetus to Adolescent 1994; 5: 86-8.
28. Coplan J, Contello KA, Cunningham CK, Weiner LB, Dye TD, Roberge L, et al. Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics 1998; 102: 8.
29. Wolters P, Brouwers P, Moss HA, Pizzo PA. Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics 1995; 95: 112-9.
30. Wolters PL, Browers P, Civitello L, Moss HA. Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study. AIDS 1997; 11: 1135-44.
31. Ultmann MH, Diamond GW, Ruff HA, Belman AL, Novick BE, Rubinstein A, et al. Developmental abnormalities in children with acquired immunodeficiency syndrome (aids): a follow up study. Int J Neurosci 1987; 32: 661-7.
32. Belmam AL, Diamond G, Dickson D, Horoupian D, Llena J, Lantos G, et al. Pediatric acquired immunodeficiency syndrome: neurologic syndromes. Am J Dis Child 1988; 142: 29-35.
33. Aylward EH, Butz AM, Hutton N, Joyner ML, Wogelhut JW. Cognitive and motor development in infants at risk for human immunodeficiency virus. Am J Dis Child 1992; 146: 218-22.
34. Msellati P, Lepage P, Hitimana DG, Van Goethem C, Van de Perre P, Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics 1993; 92: 843-8.
35. Boivin MJ, Green SD, Davies AG, Giordani B, Mokili JK, Cutting WA. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol 1995; 14: 13-21.
36. Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319: 889-96.
37. McKinney RE, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 1991; 324: 1018-25.
38. Brady MT, McGrath N, Brouwers P, Gelber R, Fowler MG, Yogev R, et al. Randomized study of the tolerance and efficacy of high-versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (aids clinical trials group 128). J Infect Dis 1996; 173: 1097-106.
39. Moss HA, Brouwers P, Wolters PL, Wiener L, Hersh S, Pizzo PA. The development of a Q-sort behavioral rating procedure for pediatric HIV patients. J Pediatr Psychol 1994; 19: 27-46.
40. Wolters PL, Browers P, Moss HA, Pizzo PA. Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy. J Pediatr Psychol 1994; 19: 47-61.
41. Mintz M, Tardieu M, Hoyt L, McSherry G, Meldenson J, Oleske J. Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes. Neurology 1996; 46: 1583-5.
42. Raskino C, Pearson D, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimenes. Pediatrics 1999; 104: 32-41.
43. McCoig C, Castrejón MM, De Suman O, Báez C, Redondo W, McClernon D, et al. Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. J Pediatr 2002; 141: 36-44.
44. Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J. Neurocognitive functioning in pediatric human immunodeficiency virus infection. Arch Pediatr Adolesc Med 2005; 159: 651-6.
45. Jeremy RJ, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton SI, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005; 115: 380-7.
46. Lezak MD. Neuropsychological assessment. 3 ed. New York: Oxford University Press; 1995.
47. Maganto C, Amador JA, González R. Evaluación psicológica en la infancia y la adolescencia. Madrid: TEA Ediciones; 2001.
48. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R). San Antonio, TX: Psychological Corporation; 1989.
49. Wechsler D. Wechsler Intelligence Scale for Children. 3 ed (WISC-III). San Antonio, TX: Psychological Corporation; 1991.
50. Thorndike RL, Hagen EP, Satler JM. Stanford-Binet Intelligence Scale. 4 ed (S-B4). Itasca, IL: Riverside Publishing; 1986.
51. McCarthy D. McCarthy Scales of Children's Abilities. New York: Psychological Corporation; 1972.
52. Wechsler D. Manual for the Wechsler Adult Intelligence Scale Revised. San Antonio, TX: Psychological Corporation; 1981.
53. Benton AL, Sivan AB, Hamsher KS, Varney NR, Spreen O. Contributions to neuropsychological assessment. New York: Oxford University Press; 1994.
54. Hilgartner MW, Donfield SM, Willoughby A, Contant CF, Evatt BL, Gomperts ED, et al. Hemophilia growth and development study. Am J Pediatr Hematol Oncol 1993; 15: 208-18.
55. Wagner RK, Torgensen JK, Rashotte CA. The comprehensive test of phonological processing. Examiner's manual. Austin, TX: PRO-ED; 1999.
56. Wolters PL, Cool VA, Usner D, Stehbens JA, Nichols S, Loveland KA, et al. Attention in HIV-infected children. JINS 2000; 6: 443-54.
57. Fishkin PE, Armstrong FD, Routh DK, Harris L, Thompson W, Miloslavich K, et al. Brief report: relationship between HIV infection and WPPSI-R performance in preschool-age children. J Pediatr Psychol 2000; 25: 347-51.
58. Goldstein G, Nussbaum PD, Beers SR. Neuropsychology. New York: Plenum Press; 1998.
59. Conners CK. Conners' Parent Rating Scales. North Towanda, NY: Multi-Health Systems; 1990.
60. American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales. 4 ed (DSM-IV-TR). Barcelona: Masson; 2002.
61. Misdrahi D, Vila G, Funk-Brentano I, Tardieu M, Blanche S, Mouren-Simeoni MC. DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection. Eur Psychiatry 2004; 19: 182-4.
62. Portellano JA, Mateos R, Martínez-Arias R, Tapia A, Granados MJ. CUMANIN. Cuestionario de madurez neuropsicológica infantil. Madrid: TEA Ediciones; 2000.
63. Rosselli M, Matute E, Ardila A, Botero VE, Tangarife GA, Echeverría SE, et al. Evaluación neuropsicológica infantil (ENI): una batería para la evaluación de niños entre 5 y 16 años de edad. Estudio normativo colombiano. Rev Neurol 2004; 38: 720-31.
64. Lindsey JC, Hughes MD, McKinney RE, Cowles MK, Englund JA, Baker CJ, et al. Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. J Infect Dis 2000; 182: 385-93.
65. Pearson D, McGrath NM, Nozyce M, Nichols SL, Raskino C, Brouwers P, et al. Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatrics 2000; 106: 76-85.
66. Bayley N. Manual for the Bayley Scales of Infant Development. San Antonio, TX: Psychological Corporation; 1969.
67. Gay CL, Armstrong FD, Cohen D, Lay S, Hardy MD, Swales TP, et al. The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with reported drug use: birth to 24 months. Pediatrics 1995; 96: 1078-82.
68. Llorente AM, Turcich M, Lawrence KA. Differences in neuropsychological performance associated with ethnicity in children with HIV-1 infection: preliminary findings. Appl Psychol 2004; 11: 47-53.
69. Coplan J. Early Language Milestone Scale (ELM-Scale). Austin, TX: PRO-ED; 1987.
70. Frankenburg WK, Dodds JB. The Denver Develop-Mental Screening Test. J Pediatr 1967; 71: 181-91.
71. Frankenburg WK, Goldstein AD, Camp BW. The revised DDST: its accuracy as a screening instrument. J Pediatr 1971; 79: 744-53.
72. Turner B, Eppes S, McKee L, Cosler L, Mrkon LA. population based comparison of the clinical course of children and adults with aids. AIDS 1995; 9: 65-72.
73. Nozyce M, Hoberman M, Arpadi S, Wiznia A, Lambert G, Dobroszycri J, et al. A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV infected inner city children. AIDS 1994; 8: 635-9.
74. Mok JY, Ross A, Raab G, Hamilton B, Gilkinson S, Johnstone FD. Maternal HIV and drug use: effect on health and social morbidity. Arch Dis Child 1996; 74: 210-4.
75. Hirschfeld S, Moss H, Dragisic K, Smith W, Pizzo PA. Pain in pediatric human immunodeficiency virus infection: Incidence and characteristics in a single-institution pilot study. Pediatrics 1996; 98: 449-52.